🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
Our study is a prospective double-blind randomized study performed in the E...
Status
Unknown
Location
University of Monastir
Start Date
2019-05-20
Trial ID
NCT04016220
Treatments Being Tested
The aim of the study is to determine the effectiveness of nebulized azithro...
Status
Completed
Location
Alexandria University
Start Date
2024-10-02
Trial ID
NCT06584474
Treatments Being Tested
The purpose of the study is to determine the appropriate dose of fluticason...
Status
Completed
Location
Research Site
Start Date
2006-11
Trial ID
NCT00403286
Subjects who have documented exposure to SARS-CoV-2 (COVID-19) will receive...
Status
Completed
Location
University of California Irvine
Start Date
2020-06-09
Trial ID
NCT04313023
Treatments Being Tested
The primary objective of this study is to generate evidence demonstrating t...
Status
Completed
Location
USA008
Start Date
2020-12-22
Trial ID
NCT04677543
Treatments Being Tested
This is a phase one study to evaluate the safety, tolerability, and bioavai...
Status
Completed
Location
Contract Research Organization (CRO) appointed by Altair Therapeutics--Altair's offices are in:
Start Date
2008-04
Trial ID
NCT00658749
Treatments Being Tested
The purpose is to determine if single doses of PUL-042 inhalation solution ...
Status
Completed
Location
ICON Development Solutions
Start Date
2014-02
Trial ID
NCT02124278
Treatments Being Tested
This Phase 1/2, first-in-human study evaluated the safety and tolerability ...
Status
Completed
Location
University of Alabama at Birmingham
Start Date
2018-05-10
Trial ID
NCT03375047
Treatments Being Tested
This study is designed to investigate the safety and tolerability of AIR001...
Status
Completed
Location
DaVita Clinical Research
Start Date
2008-12
Trial ID
NCT00814645
Treatments Being Tested
This is a multi-center, randomized, double-blind, placebo-controlled, paral...
Status
Completed
Location
1st Affiliated Hospital of Guangzhou Medical University
Start Date
2023-03-10
Trial ID
NCT05743075
Treatments Being Tested